1. Home
  2. ALLR vs ARBB Comparison

ALLR vs ARBB Comparison

Compare ALLR & ARBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • ARBB
  • Stock Information
  • Founded
  • ALLR 2004
  • ARBB 1997
  • Country
  • ALLR United States
  • ARBB Singapore
  • Employees
  • ALLR N/A
  • ARBB N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • ARBB EDP Services
  • Sector
  • ALLR Health Care
  • ARBB Technology
  • Exchange
  • ALLR Nasdaq
  • ARBB Nasdaq
  • Market Cap
  • ALLR 15.8M
  • ARBB 18.3M
  • IPO Year
  • ALLR N/A
  • ARBB 2023
  • Fundamental
  • Price
  • ALLR $1.73
  • ARBB $7.45
  • Analyst Decision
  • ALLR Strong Buy
  • ARBB Strong Buy
  • Analyst Count
  • ALLR 1
  • ARBB 1
  • Target Price
  • ALLR $9.25
  • ARBB $20.00
  • AVG Volume (30 Days)
  • ALLR 641.5K
  • ARBB 970.5K
  • Earning Date
  • ALLR 11-13-2025
  • ARBB 11-26-2025
  • Dividend Yield
  • ALLR N/A
  • ARBB N/A
  • EPS Growth
  • ALLR N/A
  • ARBB N/A
  • EPS
  • ALLR N/A
  • ARBB N/A
  • Revenue
  • ALLR N/A
  • ARBB $24,425,491.00
  • Revenue This Year
  • ALLR N/A
  • ARBB N/A
  • Revenue Next Year
  • ALLR N/A
  • ARBB $462.92
  • P/E Ratio
  • ALLR N/A
  • ARBB N/A
  • Revenue Growth
  • ALLR N/A
  • ARBB N/A
  • 52 Week Low
  • ALLR $0.61
  • ARBB $3.62
  • 52 Week High
  • ALLR $2.35
  • ARBB $18.60
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 58.71
  • ARBB 53.30
  • Support Level
  • ALLR $1.54
  • ARBB $7.25
  • Resistance Level
  • ALLR $1.65
  • ARBB $8.90
  • Average True Range (ATR)
  • ALLR 0.13
  • ARBB 1.72
  • MACD
  • ALLR -0.01
  • ARBB -0.12
  • Stochastic Oscillator
  • ALLR 72.97
  • ARBB 30.93

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

About ARBB ARB IOT Group Limited

ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.

Share on Social Networks: